The publisher's Medical Devices sector report, “Transcatheter Heart Valves Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Transcatheter Heart Valves pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Transcatheter heart valves are synthetic valves made from biological tissues surrounded by a steel, cobalt-chromium, or nitinol stent. These valves can be either balloon expandable or self-expandable.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Transcatheter heart valves are synthetic valves made from biological tissues surrounded by a steel, cobalt-chromium, or nitinol stent. These valves can be either balloon expandable or self-expandable.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Transcatheter Heart Valves under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Transcatheter Heart Valves and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Transcatheter Heart Valves under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Transcatheter Heart Valves Overview
3 Products under Development
3.1 Transcatheter Heart Valves - Pipeline Products by Stage of Development
3.2 Transcatheter Heart Valves - Pipeline Products by Segment
3.3 Transcatheter Heart Valves - Pipeline Products by Territory
3.4 Transcatheter Heart Valves - Pipeline Products by Regulatory Path
3.5 Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date
3.6 Transcatheter Heart Valves - Ongoing Clinical Trials
4 Transcatheter Heart Valves - Pipeline Products under Development by Companies
4.1 Transcatheter Heart Valves Companies - Pipeline Products by Stage of Development
4.2 Transcatheter Heart Valves - Pipeline Products by Stage of Development
5 Transcatheter Heart Valves Companies and Product Overview
6 Transcatheter Heart Valves- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
- Transcatheter Heart Valves - Pipeline Products by Stage of Development
- Transcatheter Heart Valves - Pipeline Products by Segment
- Transcatheter Heart Valves - Pipeline Products by Territory
- Transcatheter Heart Valves - Pipeline Products by Regulatory Path
- Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date
- Transcatheter Heart Valves - Ongoing Clinical Trials
- Transcatheter Heart Valves Companies - Pipeline Products by Stage of Development
- Transcatheter Heart Valves - Pipeline Products by Stage of Development
- Glossary
- Transcatheter Heart Valves - Pipeline Products by Stage of Development
- Transcatheter Heart Valves - Pipeline Products by Segment
- Transcatheter Heart Valves - Pipeline Products by Territory
- Transcatheter Heart Valves - Pipeline Products by Regulatory Path
- Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date
- Transcatheter Heart Valves - Ongoing Clinical Trials
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3DT Holdings LLC
- 4C Medical Technologies Inc
- Abbott Vascular Inc
- Aegis Surgical Limited
- Affluent Medical SASU
- Anchorvalve
- Annulon
- Anteris Technologies Ltd
- AorTx, Inc.
- Arbor Surgical Technologies, Inc.
- Atlas Medical
- AVVie GmbH
- Biotronik AG
- Boston Children's Hospital
- Boston Scientific Corp
- Cardiac Dimensions Inc
- CardioMech AS
- Cardiovalve Ltd
- Carena Healthcare Ltd
- Cephea Valve Technologies, Inc.
- Chengdu Silara Meditech Inc
- Colibri Heart Valve LLC
- ContiTech (Beijing) Medical Technology Co Ltd
- coramaze technologies GmbH
- Daidalos Solutions BV
- Direct Flow Medical Inc (Inactive)
- DSM Dyneema BV
- Dura LLC
- Edwards Lifesciences Corp
- Emory University
- Endoluminal Technology Research LLC
- Endomimetics LLC
- Enlight Medical Technologies (Shanghai) Co Ltd
- Florida International University
- Folda LLC
- Foldax Inc
- Half Moon Medical Inc
- Hangzhou DeJin Medtech Co Ltd
- Hangzhou Valgen Medtech Co Ltd
- Hangzhou Valued Medtech Co Ltd
- HighLife SAS
- HLT, Inc.
- InnovHeart SRL
- JC Medical, Inc.
- JenaValve Technology GmbH
- Jenscare Scientific Co Ltd
- Jiangsu Zhenyi Medical Technology Co Ltd
- Jinshi Biotechnology (Changshu) Co Ltd
- Kekai Life Sciences
- KOKA Lifesciences Co Ltd
- LaPlace Interventional Inc
- Lepu Medical Technology (Beijing) Co Ltd
- LivaNova PLC
- Mayo Clinic
- Medfree Inc
- Medtentia International Ltd Oy
- Medtronic Plc
- Meril Life Sciences Pvt Ltd
- Micro Interventional Devices, Inc.
- MicroPort CardioFlow Medtech Corp
- MicroPort MedBot (Shanghai) Co Ltd
- MicroPort Scientific Corp
- Mitral Heal
- Mitralix Ltd.
- MitrAssist Ltd.
- Mitria Medical LLC
- MValve Technologies Ltd.
- Nanjing Shengde Medical Technology Co Ltd
- NaviGate Cardiac Structures, Inc.
- Neochord Inc
- Neovasc Inc
- NewMed Medical Co Ltd
- North Carolina State University
- Novogate Medical Ltd.
- NVT AG
- Nyra Medical Inc
- Open Stent Solution
- Opsens Inc
- OrbusNeich P&F
- P+F Products + Features GmbH
- Peca Labs Inc
- Peijia Medical Ltd
- Pi-Cardia Ltd
- Pipeline Medical Technologies Inc
- Polares Medical SA
- PolyNova Cardiovascular Inc
- Polyvascular Corp
- RegenaGraft
- ReValve Med Inc
- RUA Life Sciences Plc
- SAS Cormove
- Shanghai Hanyu Medical Technology Co Ltd
- Shanghai Healing Medical Instruments Co Ltd
- Shanghai Huihe Medical Technology Co Ltd
- Shanghai Shenqi Medical Technology Co Ltd
- Sino Medical Sciences Technology Inc
- St. Jude Medical LLC
- Stony Brook University
- Strait Access Technologies (Pty) Ltd
- Sutra Medical Inc
- Symetis SA
- The University of British Columbia
- Thubrikar Aortic Valve, Inc.
- Tioga Medical Inc
- Trinity College Dublin
- Trisol Medical Ltd
- University College London
- University of California
- University of California San Francisco
- University of Cambridge
- University of Iowa
- University of Pennsylvania
- Valcare Medical
- VALFIX Medical Ltd
- Valtech Cardio Ltd
- Vascudyne Inc
- Vascular Concepts Ltd
- Vascular Innovations Co Ltd
- Venus Medtech Hangzhou Inc
- Venus MedTech of America
- Vesalius Cardiovascular Inc
- Vvital Biomed Ltd
- Xeltis AG
- Youngheartvalve LLC
